As of April 15, 2025, Alteogen (196170.KQ) has a market cap of $13.96 billion USD. According to our data, Alteogen is ranked No.1230 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 15, 2025 | $13.96 B |
21.00%
|
Dec 30, 2024 | $11.54 B |
214.21%
|
Dec 28, 2023 | $3.67 B |
157.52%
|
Dec 29, 2022 | $1.43 B |
-39.37%
|
Dec 30, 2021 | $2.35 B |
-36.81%
|
Dec 30, 2020 | $3.72 B |
437.22%
|
Dec 30, 2019 | $0.69 B |
133.92%
|
Dec 28, 2018 | $0.30 B |
28.83%
|
Dec 28, 2017 | $0.23 B |
35.57%
|
Dec 29, 2016 | $0.17 B |
-17.51%
|
Dec 30, 2015 | $0.21 B |
57.85%
|
Dec 30, 2014 | $0.13 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
Market Cap | = | 196170.KQ Stock Price | * | 196170.KQ Shares Outstanding |
= | $261.93 | * | 53.30 M | |
= | $13.96 B |